• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的认知障碍:流行病学、临床特征、保护因素和风险因素。

Cognitive Impairment in Parkinson's Disease: Epidemiology, Clinical Profile, Protective and Risk Factors.

作者信息

Gonzalez-Latapi Paulina, Bayram Ece, Litvan Irene, Marras Connie

机构信息

Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, ON M5T2S8, Canada.

Parkinson and Other Movement Disorders Center, Department of Neurosciences, University of California San Diego, La Jolla, CA 92093, USA.

出版信息

Behav Sci (Basel). 2021 May 13;11(5):74. doi: 10.3390/bs11050074.

DOI:10.3390/bs11050074
PMID:34068064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8152515/
Abstract

Cognitive impairment is a common non-motor symptom in Parkinson's Disease (PD) and an important source of patient disability and caregiver burden. The timing, profile and rate of cognitive decline varies widely among individuals with PD and can range from normal cognition to mild cognitive impairment (PD-MCI) and dementia (PDD). Beta-amyloid and tau brain accumulation, oxidative stress and neuroinflammation are reported risk factors for cognitive impairment. Traumatic brain injury and pesticide and tobacco exposure have also been described. Genetic risk factors including genes such as , and may also play a role. Less is known about protective factors, although the Mediterranean diet and exercise may fall in this category. Nonetheless, there is conflicting evidence for most of the factors that have been studied. The use of inconsistent criteria and lack of comprehensive assessment in many studies are important methodological issues. Timing of exposure also plays a crucial role, although identification of the correct time window has been historically difficult in PD. Our understanding of the mechanism behind these factors, as well as the interactions between gene and environment as determinants of disease phenotype and the identification of modifiable risk factors will be paramount, as this will allow for potential interventions even in established PD.

摘要

认知障碍是帕金森病(PD)常见的非运动症状,是患者残疾和照料者负担的重要来源。PD患者的认知衰退时间、特征和速度差异很大,范围可从正常认知到轻度认知障碍(PD-MCI)和痴呆(PDD)。据报道,β-淀粉样蛋白和tau蛋白在脑内蓄积、氧化应激和神经炎症是认知障碍的危险因素。也有关于创伤性脑损伤以及接触杀虫剂和烟草的描述。包括某些基因等在内的遗传危险因素可能也起作用。关于保护因素了解较少,不过地中海饮食和运动可能属于此类。尽管如此,对于大多数已研究的因素,证据存在矛盾。许多研究中使用的标准不一致以及缺乏全面评估是重要的方法学问题。暴露时间也起着关键作用,尽管在PD中确定正确的时间窗历来都很困难。我们对这些因素背后机制的理解,以及基因与环境之间作为疾病表型决定因素的相互作用,还有可改变危险因素的识别至关重要,因为这将使我们即使在已确诊的PD中也能进行潜在干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ad/8152515/98867cfead72/behavsci-11-00074-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ad/8152515/98867cfead72/behavsci-11-00074-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ad/8152515/98867cfead72/behavsci-11-00074-g001.jpg

相似文献

1
Cognitive Impairment in Parkinson's Disease: Epidemiology, Clinical Profile, Protective and Risk Factors.帕金森病中的认知障碍:流行病学、临床特征、保护因素和风险因素。
Behav Sci (Basel). 2021 May 13;11(5):74. doi: 10.3390/bs11050074.
2
Incidence of Mild Cognitive Impairment and Dementia in Parkinson's Disease: The Parkinson's Disease Cognitive Impairment Study.帕金森病患者轻度认知障碍和痴呆的发病率:帕金森病认知障碍研究
Front Aging Neurosci. 2019 Feb 8;11:21. doi: 10.3389/fnagi.2019.00021. eCollection 2019.
3
Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.帕金森病中的轻度认知障碍及其向痴呆症的进展:登比郡队列的16年结局评估。
Int J Geriatr Psychiatry. 2015 Oct;30(10):1048-55. doi: 10.1002/gps.4261. Epub 2015 Feb 11.
4
Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment.载脂蛋白Eε4:轻度认知障碍帕金森病患者执行功能障碍的生物标志物。
Front Neurosci. 2017 Dec 20;11:712. doi: 10.3389/fnins.2017.00712. eCollection 2017.
5
Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.认知特征及常规认知测试在老年帕金森病、帕金森病痴呆、阿尔茨海默病及认知正常个体中的最佳截断值。
Psychogeriatrics. 2020 Jan;20(1):20-27. doi: 10.1111/psyg.12451. Epub 2019 Mar 25.
6
Cognitive impairment in early-stage non-demented Parkinson's disease patients.早期非痴呆帕金森病患者的认知障碍。
Acta Neurol Scand. 2014 May;129(5):307-18. doi: 10.1111/ane.12189. Epub 2013 Oct 11.
7
Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.探讨帕金森病中运动障碍、血管负担与认知之间的关系。
J Neurol. 2018 Jun;265(6):1320-1327. doi: 10.1007/s00415-018-8838-3. Epub 2018 Mar 23.
8
Parkinson's disease dementia: Diagnostic criteria and risk factor review.帕金森病痴呆:诊断标准与风险因素综述
J Clin Exp Neuropsychol. 2015;37(9):988-93. doi: 10.1080/13803395.2015.1073227.
9
The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease.帕金森病认知障碍和痴呆的遗传基础
Front Psychiatry. 2016 May 20;7:89. doi: 10.3389/fpsyt.2016.00089. eCollection 2016.
10
Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment.帕金森病认知障碍患者的临床特征
Front Neurol. 2020 Aug 4;11:731. doi: 10.3389/fneur.2020.00731. eCollection 2020.

引用本文的文献

1
The Role of Cognitive Reserve in Coping with Subjective Cognitive Complaints: An Exploratory Study of People with Parkinson's Disease (PwPD).认知储备在应对主观认知主诉中的作用:帕金森病患者的探索性研究
Brain Sci. 2025 Jul 25;15(8):795. doi: 10.3390/brainsci15080795.
2
Modeling and validation of wearable sensor-based gait parameters in Parkinson's disease patients with cognitive impairment.帕金森病认知障碍患者基于可穿戴传感器的步态参数建模与验证
Front Aging Neurosci. 2025 Jul 25;17:1590224. doi: 10.3389/fnagi.2025.1590224. eCollection 2025.
3
Spatial memory deficits in Parkinson's disease: neural mechanisms and assessment.

本文引用的文献

1
Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's Disease.帕金森病中与认知衰退相关的可改变共病
Mov Disord Clin Pract. 2021 Jan 20;8(2):254-263. doi: 10.1002/mdc3.13143. eCollection 2021 Feb.
2
Prevalence of Non-Motor Symptoms and Non-Motor Fluctuations in Parkinson's Disease Using the MDS-NMS.使用MDS-NMS评估帕金森病非运动症状和非运动波动的患病率
Mov Disord Clin Pract. 2020 Dec 21;8(2):231-239. doi: 10.1002/mdc3.13122. eCollection 2021 Feb.
3
Mediterranean-Type Dietary Pattern and Physical Activity: The Winning Combination to Counteract the Rising Burden of Non-Communicable Diseases (NCDs).
帕金森病中的空间记忆缺陷:神经机制与评估
Am J Neurodegener Dis. 2025 Jun 15;14(3):67-81. doi: 10.62347/CKGV8650. eCollection 2025.
4
A domain-based framework for cognitive profile identification in Parkinson's disease across diverse samples.一种基于领域的框架,用于跨不同样本识别帕金森病的认知概况。
Front Neuroanat. 2025 Jun 19;19:1566835. doi: 10.3389/fnana.2025.1566835. eCollection 2025.
5
The genetic architecture of Parkinson's disease in Morocco: highlighting a predominance of Mendelian genes.摩洛哥帕金森病的遗传结构:突出孟德尔基因的主导地位。
Neurodegener Dis. 2025 May 20:1-15. doi: 10.1159/000546424.
6
Association between cognitive and autonomic dysfunctions in patients with de novo Parkinson's disease.初发帕金森病患者认知功能障碍与自主神经功能障碍之间的关联
Sci Rep. 2025 Apr 19;15(1):13535. doi: 10.1038/s41598-025-98508-9.
7
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach.握拳-手掌测试可能识别帕金森病中的轻度认知障碍和步态冻结:一种机器学习方法。
Mov Disord Clin Pract. 2025 Aug;12(8):1105-1112. doi: 10.1002/mdc3.70080. Epub 2025 Apr 19.
8
Neuroprotective effect of cedrol in a male rat model of Parkinson's disease.雪松醇对帕金森病雄性大鼠模型的神经保护作用。
Physiol Rep. 2025 Apr;13(7):e70309. doi: 10.14814/phy2.70309.
9
Lifestyle Interventions and Innovative Approaches for the Management of Neurodegenerative Disorders in Older Adults-State-Of-The-Art and Future Directions.老年人神经退行性疾病管理的生活方式干预与创新方法——现状与未来方向
Am J Lifestyle Med. 2025 Mar 28:15598276251330170. doi: 10.1177/15598276251330170.
10
Sex Differences for Social Determinants Associated with Lewy Body Dementia Onset and Diagnosis.与路易体痴呆症发病和诊断相关的社会决定因素的性别差异。
Neurodegener Dis. 2025 Feb 18;25(1):1-13. doi: 10.1159/000544772.
地中海式饮食模式和身体活动:抵抗非传染性疾病(NCDs)负担上升的最佳组合。
Nutrients. 2021 Jan 28;13(2):429. doi: 10.3390/nu13020429.
4
The Role of Glial Mitochondria in α-Synuclein Toxicity.胶质细胞线粒体在α-突触核蛋白毒性中的作用。
Front Cell Dev Biol. 2020 Nov 11;8:548283. doi: 10.3389/fcell.2020.548283. eCollection 2020.
5
Clinical correlates of serum 25-hydroxyvitamin D in Parkinson's disease.帕金森病患者血清 25-羟维生素 D 水平的临床相关性。
Nutr Neurosci. 2022 Jun;25(6):1128-1136. doi: 10.1080/1028415X.2020.1840117. Epub 2020 Nov 5.
6
Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study.帕金森病患者的认知障碍:一项大型纵向研究中主观和客观认知下降之间的关联。
Parkinsonism Relat Disord. 2020 Nov;80:127-132. doi: 10.1016/j.parkreldis.2020.09.028. Epub 2020 Sep 20.
7
Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.血管危险因素、帕金森病中的脑白质病变与认知障碍:PACOS 纵向研究。
J Neurol. 2021 Feb;268(2):549-558. doi: 10.1007/s00415-020-10189-8. Epub 2020 Aug 31.
8
Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.路易体痴呆与帕金森病痴呆的新临床病理特征有别。
Neuropathol Appl Neurobiol. 2021 Feb;47(1):143-156. doi: 10.1111/nan.12648. Epub 2020 Aug 12.
9
The effect of the Mediterranean diet on cognitive function in patients with Parkinson's disease: A randomized clinical controlled trial.地中海饮食对帕金森病患者认知功能的影响:一项随机临床对照试验。
Complement Ther Med. 2020 May;50:102366. doi: 10.1016/j.ctim.2020.102366. Epub 2020 Mar 4.
10
The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.2 型糖尿病与帕金森病的关联。
J Parkinsons Dis. 2020;10(3):775-789. doi: 10.3233/JPD-191900.